Alvotech and Teva Announce U.S. Approval of SIMLANDI®
SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first biosimilar...
Stay updated with breaking news from Yonatan Beker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first biosimilar...
SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first biosimilar...
SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first biosimilar approval under the strategic partnership...
Healthcare providers called the shift “very concerning,” and drug market experts said the sophistication of the faux bottles points to the involvement of large criminal organizations.
A new round of testing found that counterfeiters are now passing off a wider array of substances as attention deficit/hyperactivity disorder medications and selling the pills not only as Adderall but sometimes as a similar medication called Vyvanse.